Regeneron Pharmaceuticals
Price & Volume
Stats
See more52W Range | $538.54-$818.90 |
Market Cap | $69.6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $14.9B |
Revenue Growth (YoY) | 19% |
Gross Profit (12 Mos) | $6.5B |
Diluted EPS | $40.93 |
News
See moreYahoo Finance • 4 days ago
Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis
Yahoo Finance • 10 days ago
Dupilumab Achieves Record $11.9 Billion in Global Sales Amidst Continued Growth
Yahoo Finance • 13 days ago
Talawar Therapeutics to debut on Nasdaq with $285m as Dupixent challenger
Yahoo Finance • 13 days ago
Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing
About
CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
CFO | Mr. Christopher R. Fenimore CPA |
Address | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15,343 |